Market Access Archives

Publication

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…

Jim Gallagher2021年4月8日

Article

Legislators: Bring all stakeholders to the table to lower drug costs

BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…

Certara2021年3月30日

On-Demand Webinar

Strategic Evidence & Value Communication Symposium

Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…

Certara2021年3月26日

Blog

遺伝子治療を患者へ届けるために

This blog discusses the challenges that drug developers face in getting patients access to cell…

Certara2021年2月16日

Case Study

遺伝子治療臨床試験デザインにおける早期価値評価

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

Jim Gallagher2021年2月12日

Brochure

BaseCase Market Access

Certara2020年11月30日

Article

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

Certara2020年11月20日

On-Demand Webinar

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

In this webinar, our experts provided an overview of the SNDS and the key working…

Jim Gallagher2020年10月20日

On-Demand Webinar

Payment Pressures in U.S. Specialty: Status quo and outlook for future financing

To allow for the optimal positioning of your product, portfolio, or company, it is critical…

Certara2020年9月15日

Blog

ICER’s Unsupported Drug Price Increase Report: An Analysis

We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…

Certara2019年10月24日

マーケットアクセス

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Legislators: Bring all stakeholders to the table to lower drug costs

Strategic Evidence & Value Communication Symposium

遺伝子治療を患者へ届けるために

遺伝子治療臨床試験デザインにおける早期価値評価

BaseCase Market Access

Getting Real with RWE

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

Payment Pressures in U.S. Specialty: Status quo and outlook for future financing

ICER’s Unsupported Drug Price Increase Report: An Analysis

メルマガ登録

クイックアクセス

ソリューション

お問合せ